(except Louisiana for compounded medications)
This article explores the evidence behind urinary symptoms on GLP-1 therapy and when to seek medical evaluation
ADRB2 Rabbit pAb (Cat No: bs-0947R, Lot No: BD06045837), BCL3 Rabbit pAb (Cat No: bs-6591R, Lot No: BD09029500), EGR1 Rabbit pAb (Cat No: bs-1076R, Lot No: BD07036484), FOS Rabbit pAb (Cat No: bs-0469R, Lot No: BD02036587), MAP3K8 Rabbit pAb (Cat No: bs-3591R, Lot No: BD154569821), Cleaved Caspase-3 Rabbit pAb (Cat No: bsm-61090R, Lot No: BE03195616), Caspase-3 Rabbit pAb (Cat No: bs-55032R, Lot No: BD12133918), Caspase-8 Rabbit pAb (Cat No: bs-0052R, Lot No: BD13584563), Fas Associated Via Death Domain ( FADD) Rabbit pAb (Cat No: bs-0511R, Lot No: BD11128696), Gasdermin E ( GSDME) Rabbit pAb (Cat No: bs-14286R, Lot No: BD08082111)
It also provides key nutrients such as vitamin B12, essential for brain function
The combination of GLP-1 therapy and lifestyle changes can have a profound impact on managing diabetes and improving overall health
NOTE: Time to first event was analyzed in a Cox proportional hazards model with treatment as factor
